title: Acute lymphoblastic leukemia-relapse study of the Berlin-Frankfurt-Munster Group (ALL-REZ BFM) experience: early treatment intensity makes the difference.
authors.forename: Ralf
authors.initials: R
authors.lastname: Herold
authors.forename: Arend
authors.initials: A
authors.lastname: von Stackelberg
authors.forename: Reinhard
authors.initials: R
authors.lastname: Hartmann
authors.forename: Bernhard
authors.initials: B
authors.lastname: Eisenreich
authors.forename: Günter
authors.initials: G
authors.lastname: Henze
mesh_terms: D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D018572:Disease-Free Survival; D018380:Hematopoietic Stem Cell Transplantation; D006801:Humans; D009364:Neoplasm Recurrence, Local / Q000517:prevention & control*; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis* / Q000628:therapy*; D012074:Remission Induction; D012307:Risk Factors